This invention is in the field of lymphadenopathy virus which has been designated
Human Immunodeficiency Virus Type 1 (HIV-1). This invention relates to a diagnostic
means and method to detect the presence of DNA, RNA or antibodies of the lymphadenopathy
retrovirus associated with the acquired immune deficiency syndrome or of the lymphadenopathy
syndrome by the use of DNA fragments of the peptides encoded by said DNA fragments.
The invention further relates to the DNA fragments, vectors comprising them and
the proteins expressed.